Accueil/Actions/IMMX

IMMX

USD

Immix Biopharma Inc. Common Stock

$3.150+0.140 (4.651%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$3.010

Haut

$3.220

Bas

$2.890

Volume

0.10M

Fondamentaux de l'Entreprise

Capitalisation Boursière

104.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.44M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.34Actuel $3.150Haut $4.05

Actualités Connexes

3 nov. 2025 · 13:45

GlobeNewswire

Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

- Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/refractory AL

Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025

14 oct. 2025 · 12:45

GlobeNewswire

Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference

LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. ("ImmixBio", "Company", "We" or "Us" or "IMMX"), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present